Press Release | January 23, 2026
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
Read More
Press Release | January 21, 2026
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
Read More
News | January 15, 2026
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
Read More
Press Release | January 8, 2026
Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
Read More
